Saturday, 3 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 25, 2026

I’m 50 years old with $400K in savings, but I’ve heard the magic number for retirement is $1.26 million. Will I be okay?

View original at finance.yahoo.com
I’m 50 years old with $400K in savings, but I’ve heard the magic number for retirement is $1.26 million. Will I be okay? AnnaStills / Getty Images Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Most Americans are reaching for $1.26M as their magic number for retiring comfortably

    80% confidence
  • Total average expenditures for Americans 65 or over was $61,432 in 2024

    80% confidence
  • Gen Xers have a median 401(k) balance of $217,500

    80% confidence
  • Nearly 50% of Americans are making 1 big Social Security mistake

    80% confidence
  • One asset will surge 400% in a year

    80% confidence
  • Average 401(k) balance among savers aged 50 to 54 was $199,900 as of Q4 2024

    80% confidence
  • Typical retired worker today collects about $2,071 per month in Social Security benefits

    80% confidence
  • Warning issued about what could be coming for U.S. stocks, raising alarm bells for retirees

    80% confidence
  • Social Security fund projected to run out in late 2032, but employer payroll taxes will still fund majority of benefits

    80% confidence
  • Typical 65-year-old could expect to spend $172,500 on health care and medical expenses throughout retirement in 2025

    80% confidence
  • Standard monthly cost for Medicare Part B in 2026 is $202.90

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com